Who Owns Standard BioTools Stock?
NASDAQ: LABIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 74.57%
- Held by insiders
- 1.85%
- Institutional holders
- 150
- Institutions 74.6%
- Insiders 1.8%
- Public and other 23.6%
Who owns Standard BioTools stock?
Institutional investors own about 74.6% of Standard BioTools's shares, spread across 150 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 1.85% of LAB.
The largest institutional holders are Casdin Capital, LLC (22.49%), Viking Global Investors, L.P. (14.86%) and MAK Capital One LLC (7.30%). Together, the top 10 institutions control 60.4% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their LAB positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of LAB
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Casdin Capital, LLC | 88.78M | 22.49% | 0.0% |
| Viking Global Investors, L.P. | 58.65M | 14.86% | 0.0% |
| MAK Capital One LLC | 28.81M | 7.30% | +10.1% |
| Long Focus Capital Management, LLC | 23.50M | 5.95% | +46.7% |
| Vanguard Capital Management LLC | 12.50M | 3.17% | +2.0% |
| Blackrock Inc. | 8.26M | 2.09% | +0.0% |
| Hollow Brook Wealth Management LLC | 5.20M | 1.32% | -5.5% |
| Qube Research & Technologies Ltd | 4.94M | 1.25% | +2.4% |
| Neuberger Berman Group, LLC | 4.35M | 1.10% | -12.3% |
| Geode Capital Management, LLC | 3.56M | 0.90% | -8.7% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of LAB
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 8.43M | 2.14% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 3.42M | 0.87% |
| iShares Trust-iShares Biotechnology ETF | 2.93M | 0.74% |
| ROYCE MICRO-CAP TRUST, INC.-Royce Micro-Cap Trust Inc | 2.87M | 0.73% |
| SCHWAB STRATEGIC TRUST-Schwab U.S. Small-Cap ETF | 1.42M | 0.36% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 1.37M | 0.35% |
| ROYCE FUND-Royce Micro-Cap Fund | 1.25M | 0.32% |
| NEUBERGER BERMAN EQUITY FUNDS-Neuberger Intrinsic Value Fund | 1.04M | 0.26% |
| VANGUARD WORLD FUND-Vanguard Health Care Index Fund | 682.90K | 0.17% |
| MORGAN STANLEY INSTITUTIONAL FUND INC-Inception Portfolio | 654.87K | 0.17% |
Frequently asked questions
Who is the largest shareholder of Standard BioTools?
Casdin Capital, LLC is the largest institutional shareholder of LAB, owning 22.49% of shares outstanding (88.78M shares) as of its latest 13F filing.
What percentage of Standard BioTools is owned by institutions?
Institutions own about 74.6% of LAB shares and 76.0% of the public float.
How much of Standard BioTools do insiders own?
Insiders, such as officers and directors, own about 1.85% of LAB shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.